Rapid HIV-1 testing during labor

A multicenter study

Marc Bulterys, Denise J. Jamieson, Mary Jo O'Sullivan, Mardge H. Cohen, Robert Maupin, Steven Nesheim, Mayris P. Webber, Russell Van Dyke, Jeffrey Wiener, Bernard M. Branson

Research output: Contribution to journalArticle

171 Citations (Scopus)

Abstract

Context: Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis. Objectives: To determine the feasibility and acceptance of rapid HIV testing among women in labor and to assess rapid HIV assay performance. Design, Setting, and Patients: The Mother-Infant Rapid Intervention At Delivery (MIRIAD) study implemented 24-hour counseling and voluntary rapid HIV testing for women in labor at 16 US hospitals from November 16, 2001, through November 15, 2003. A rapid HIV-1 antibody test for whole blood was used. Main Outcome Measures: Acceptance of HIV testing; sensitivity, specificity, and predictive value of the rapid test; time from blood collection to patient notification of results. Results: There were 91 707 visits to the labor and delivery units in the study, 7381 of which were by eligible women without documentation of HIV testing. Of these, 5744 (78%) women were approached for rapid HIV testing and 4849 (84%) consented. HIV-1 test results were positive for 34 women (prevalence=7/1000). Sensitivity and specificity of the rapid test were 100% and 99.9%, respectively; positive predictive value was 90% compared with 76% for enzyme immunoassay (EIA). Factors independently associated with higher test acceptance included younger age, being black or Hispanic, gestational age less than 32 weeks, and having had no prenatal care. Lower acceptance was associated with being admitted between 4 PM and midnight, particularly on Friday nights, but this may be explained in part by fewer available personnel. Median time from blood collection to patient notification of result was 66 minutes (interquartile range, 45-120 minutes), compared with 28 hours for EIA (P<.001). Conclusions: Rapid HIV testing is feasible and delivers accurate and timely test results for women in labor. It provides HIV-positive women prompt access to intrapartum and neonatal antiretroviral prophylaxis, proven to reduce perinatal HIV transmission, and may be particularly applicable to higher-risk populations.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalJournal of the American Medical Association
Volume292
Issue number2
DOIs
StatePublished - Jul 14 2004

Fingerprint

Multicenter Studies
HIV-1
HIV
Immunoenzyme Techniques
Predictive Value of Tests
Sensitivity and Specificity
Prenatal Care
Hematologic Tests
Hispanic Americans
Documentation
Gestational Age
Counseling
Mothers
Outcome Assessment (Health Care)
Antibodies
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bulterys, M., Jamieson, D. J., O'Sullivan, M. J., Cohen, M. H., Maupin, R., Nesheim, S., ... Branson, B. M. (2004). Rapid HIV-1 testing during labor: A multicenter study. Journal of the American Medical Association, 292(2), 219-223. https://doi.org/10.1001/jama.292.2.219

Rapid HIV-1 testing during labor : A multicenter study. / Bulterys, Marc; Jamieson, Denise J.; O'Sullivan, Mary Jo; Cohen, Mardge H.; Maupin, Robert; Nesheim, Steven; Webber, Mayris P.; Van Dyke, Russell; Wiener, Jeffrey; Branson, Bernard M.

In: Journal of the American Medical Association, Vol. 292, No. 2, 14.07.2004, p. 219-223.

Research output: Contribution to journalArticle

Bulterys, M, Jamieson, DJ, O'Sullivan, MJ, Cohen, MH, Maupin, R, Nesheim, S, Webber, MP, Van Dyke, R, Wiener, J & Branson, BM 2004, 'Rapid HIV-1 testing during labor: A multicenter study', Journal of the American Medical Association, vol. 292, no. 2, pp. 219-223. https://doi.org/10.1001/jama.292.2.219
Bulterys M, Jamieson DJ, O'Sullivan MJ, Cohen MH, Maupin R, Nesheim S et al. Rapid HIV-1 testing during labor: A multicenter study. Journal of the American Medical Association. 2004 Jul 14;292(2):219-223. https://doi.org/10.1001/jama.292.2.219
Bulterys, Marc ; Jamieson, Denise J. ; O'Sullivan, Mary Jo ; Cohen, Mardge H. ; Maupin, Robert ; Nesheim, Steven ; Webber, Mayris P. ; Van Dyke, Russell ; Wiener, Jeffrey ; Branson, Bernard M. / Rapid HIV-1 testing during labor : A multicenter study. In: Journal of the American Medical Association. 2004 ; Vol. 292, No. 2. pp. 219-223.
@article{02d0667703a24de9b7fa62a2fbf70fef,
title = "Rapid HIV-1 testing during labor: A multicenter study",
abstract = "Context: Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis. Objectives: To determine the feasibility and acceptance of rapid HIV testing among women in labor and to assess rapid HIV assay performance. Design, Setting, and Patients: The Mother-Infant Rapid Intervention At Delivery (MIRIAD) study implemented 24-hour counseling and voluntary rapid HIV testing for women in labor at 16 US hospitals from November 16, 2001, through November 15, 2003. A rapid HIV-1 antibody test for whole blood was used. Main Outcome Measures: Acceptance of HIV testing; sensitivity, specificity, and predictive value of the rapid test; time from blood collection to patient notification of results. Results: There were 91 707 visits to the labor and delivery units in the study, 7381 of which were by eligible women without documentation of HIV testing. Of these, 5744 (78{\%}) women were approached for rapid HIV testing and 4849 (84{\%}) consented. HIV-1 test results were positive for 34 women (prevalence=7/1000). Sensitivity and specificity of the rapid test were 100{\%} and 99.9{\%}, respectively; positive predictive value was 90{\%} compared with 76{\%} for enzyme immunoassay (EIA). Factors independently associated with higher test acceptance included younger age, being black or Hispanic, gestational age less than 32 weeks, and having had no prenatal care. Lower acceptance was associated with being admitted between 4 PM and midnight, particularly on Friday nights, but this may be explained in part by fewer available personnel. Median time from blood collection to patient notification of result was 66 minutes (interquartile range, 45-120 minutes), compared with 28 hours for EIA (P<.001). Conclusions: Rapid HIV testing is feasible and delivers accurate and timely test results for women in labor. It provides HIV-positive women prompt access to intrapartum and neonatal antiretroviral prophylaxis, proven to reduce perinatal HIV transmission, and may be particularly applicable to higher-risk populations.",
author = "Marc Bulterys and Jamieson, {Denise J.} and O'Sullivan, {Mary Jo} and Cohen, {Mardge H.} and Robert Maupin and Steven Nesheim and Webber, {Mayris P.} and {Van Dyke}, Russell and Jeffrey Wiener and Branson, {Bernard M.}",
year = "2004",
month = "7",
day = "14",
doi = "10.1001/jama.292.2.219",
language = "English (US)",
volume = "292",
pages = "219--223",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Rapid HIV-1 testing during labor

T2 - A multicenter study

AU - Bulterys, Marc

AU - Jamieson, Denise J.

AU - O'Sullivan, Mary Jo

AU - Cohen, Mardge H.

AU - Maupin, Robert

AU - Nesheim, Steven

AU - Webber, Mayris P.

AU - Van Dyke, Russell

AU - Wiener, Jeffrey

AU - Branson, Bernard M.

PY - 2004/7/14

Y1 - 2004/7/14

N2 - Context: Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis. Objectives: To determine the feasibility and acceptance of rapid HIV testing among women in labor and to assess rapid HIV assay performance. Design, Setting, and Patients: The Mother-Infant Rapid Intervention At Delivery (MIRIAD) study implemented 24-hour counseling and voluntary rapid HIV testing for women in labor at 16 US hospitals from November 16, 2001, through November 15, 2003. A rapid HIV-1 antibody test for whole blood was used. Main Outcome Measures: Acceptance of HIV testing; sensitivity, specificity, and predictive value of the rapid test; time from blood collection to patient notification of results. Results: There were 91 707 visits to the labor and delivery units in the study, 7381 of which were by eligible women without documentation of HIV testing. Of these, 5744 (78%) women were approached for rapid HIV testing and 4849 (84%) consented. HIV-1 test results were positive for 34 women (prevalence=7/1000). Sensitivity and specificity of the rapid test were 100% and 99.9%, respectively; positive predictive value was 90% compared with 76% for enzyme immunoassay (EIA). Factors independently associated with higher test acceptance included younger age, being black or Hispanic, gestational age less than 32 weeks, and having had no prenatal care. Lower acceptance was associated with being admitted between 4 PM and midnight, particularly on Friday nights, but this may be explained in part by fewer available personnel. Median time from blood collection to patient notification of result was 66 minutes (interquartile range, 45-120 minutes), compared with 28 hours for EIA (P<.001). Conclusions: Rapid HIV testing is feasible and delivers accurate and timely test results for women in labor. It provides HIV-positive women prompt access to intrapartum and neonatal antiretroviral prophylaxis, proven to reduce perinatal HIV transmission, and may be particularly applicable to higher-risk populations.

AB - Context: Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis. Objectives: To determine the feasibility and acceptance of rapid HIV testing among women in labor and to assess rapid HIV assay performance. Design, Setting, and Patients: The Mother-Infant Rapid Intervention At Delivery (MIRIAD) study implemented 24-hour counseling and voluntary rapid HIV testing for women in labor at 16 US hospitals from November 16, 2001, through November 15, 2003. A rapid HIV-1 antibody test for whole blood was used. Main Outcome Measures: Acceptance of HIV testing; sensitivity, specificity, and predictive value of the rapid test; time from blood collection to patient notification of results. Results: There were 91 707 visits to the labor and delivery units in the study, 7381 of which were by eligible women without documentation of HIV testing. Of these, 5744 (78%) women were approached for rapid HIV testing and 4849 (84%) consented. HIV-1 test results were positive for 34 women (prevalence=7/1000). Sensitivity and specificity of the rapid test were 100% and 99.9%, respectively; positive predictive value was 90% compared with 76% for enzyme immunoassay (EIA). Factors independently associated with higher test acceptance included younger age, being black or Hispanic, gestational age less than 32 weeks, and having had no prenatal care. Lower acceptance was associated with being admitted between 4 PM and midnight, particularly on Friday nights, but this may be explained in part by fewer available personnel. Median time from blood collection to patient notification of result was 66 minutes (interquartile range, 45-120 minutes), compared with 28 hours for EIA (P<.001). Conclusions: Rapid HIV testing is feasible and delivers accurate and timely test results for women in labor. It provides HIV-positive women prompt access to intrapartum and neonatal antiretroviral prophylaxis, proven to reduce perinatal HIV transmission, and may be particularly applicable to higher-risk populations.

UR - http://www.scopus.com/inward/record.url?scp=3042767708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042767708&partnerID=8YFLogxK

U2 - 10.1001/jama.292.2.219

DO - 10.1001/jama.292.2.219

M3 - Article

VL - 292

SP - 219

EP - 223

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 2

ER -